Filing metadata

Accession number
0001415889-24-021057
Form type
Form 4
Filer
Theravance Biopharma, Inc.
CIK
CIK 1583107
Filed
Aug 09, 2024
Reporting period
Aug 07, 2024
Description
Insider transaction

Explore SEC Filings Hub

4 | SEC Filings Hub